Harry L. Leider

Insider Reports History

Entity
Individual
Location
C/O Gelesis, Inc., 501 Boylston Street, Suite 6102, Boston, MA
Signature
/s/ Harry L. Leider
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harry L. Leider:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GELESIS HOLDINGS, INC. Chief Medical Officer Common Stock 314K May 6, 2022 Direct
GELESIS HOLDINGS, INC. Chief Medical Officer Stock Option (Right to Buy) 270K May 6, 2022 Direct
Organicell Regenerative Medicine, Inc. Chief Executive Officer, Director Common Stock 0 $1.32 Dec 19, 2023 Indirect

Insider Reports Filed by Harry L. Leider

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OCEL Organicell Regenerative Medicine, Inc. Dec 19, 2023 1 -$6.9K 4 Dec 20, 2023 Chief Executive Officer, Director
OCEL Organicell Regenerative Medicine, Inc. Jun 28, 2023 2 $10.4K 4/A Dec 21, 2023 Chief Executive Officer, Director
OCEL Organicell Regenerative Medicine, Inc. Jun 28, 2023 2 $59.4K 4 Jun 30, 2023 Chief Executive Officer, Director
OCEL Organicell Regenerative Medicine, Inc. Jun 6, 2023 0 $0 3 Jun 9, 2023 CEO and Director, Director
GLSH GELESIS HOLDINGS, INC. May 6, 2022 4 $0 4 May 9, 2022 Chief Medical Officer
GLSH GELESIS HOLDINGS, INC. Jan 13, 2022 0 $0 3 Jan 24, 2022 Chief Medical Officer